HKU Scholars Hub: Browsing DSpace

Browsing by Author SHEK, HP

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 3 to 9 of 9 < previous

	Title	Author(s)	Issue Date	Views
	miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma Journal:PLoS ONE	Liu, ML Xu, Z Shek, HP Wong, KF Lee, NPY Poon, RTP Chen, J Luk, JMC	2014	42
	Oncofetal Molecules as Biomarkers and Drug Targets for Hepatic Cancer Book:New Advances on Disease Biomarkers and Molecular Targets in Biomedicine	Shek, HP Lai, TCW Fatima, S Lee, NPY	2013	57
	Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2 Journal:Digestive Diseases and Sciences	TSANG, FH Au, CHV LU, W SHEK, HP LIU, ML Luk, JMC Fan, ST Poon, RTP Lee, NPY	2014	44
	Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma Journal:Cellular Oncology	SHEK, HP Luo, R Lam, BYH Sung, WK Lam, TW Luk, JMC Leung, MS Chan, KT Wang, KSH Chan, CMG Poon, RTP Lee, NPY	2017	78
	Targeting Serine Peptidase Inhibitor, Kazal Type 1 (SPINK1) as a Potential Treatment for Hepatocellular Carcinoma Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2011	Shek, HP Luk, JMC Lee, NPY	2011	123
	The role of serine peptidase inhibitor, Kazal type I (SPINK1) in hepatocellular carcinoma Proceeding/Conference:Cancer Omics	Shek, HP Luk, JMC Kwong, A Lee, NPY	2010	109
	Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2011	Shek, HP Lee, NPY	2011	102

Showing results 3 to 9 of 9 < previous